AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Compounding is important for investors as it maximizes potential returns over time. Discover its significance in your investment strategy.
27,336 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A $1 million horror film defies expectations while a 30-year-old franchise returns with a bold new installment, deliv...
Home Depot faces a choppy housing backdrop even as demand proves resilient. This report weighs whether prediction: ho...
Spot Bitcoin ETFs posted a seventh straight week of net outflows, with about $1.8 billion pulled in the week ending J...
Stocks climbed on Monday after weekend actions in the Middle East, extending a pattern investors have watched in seve...
Opendoor and Offerpad led a narrow iBuyer rally with midday gains of about 7% and 6%, respectively. The move comes as...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...
Meta’s aggressive AI infrastructure push is drawing scrutiny, but a SpaceX-like monetization model could flip the scr...
BNB Chain announced a new Layer 1 focused on agentic trading, aiming for sub-50ms preconfirmation and no public mempo...
Tech earnings are delivering impressive results, yet portfolio risk is rising as technology carries a larger share of...
AscendEX has halted most platform services after failing to secure MiCA authorization. The firm warns withdrawals may...
Strategy increases its USD cash pile by $450 million via a stock offering, bringing total USD reserves to $3 billion ...